DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト

2017年11月12日 (日) 午前 9:30 - 2017年11月14日 (火) 午後 5:30

〒135-0063, 東京都江東区有明3-11-1

第14回DIA日本年会

[Student Session] Clinical Trial Protocol Development

Session Chair(s)

Maori  Ayabe

Maori Ayabe

Undergraduate Student, Faculty of Pharmaceutical Sciences, Chiba University, Japan

Shouhei  Iimura

Shouhei Iimura

Student, Keio University, Japan

Aya  Okada

Aya Okada

Pharmacovigilance, ASKA Pharmaceutical Co., Ltd., Japan

Miho  Sato

Miho Sato

Undergraduate Student, School of Pharmacy, Showa University, Japan

Clinical trials are essential for evaluating drug safety and efficacy. Moreover, consideration of subjects and choices such as trial designs and evaluation methods are important in conducting them. Therefore, how are ethical and scientific clinical trials designed? This session will provide a lecture on the essence of developing a clinical trial protocol. Subsequently, you will conduct a protocol development by group work and improve understanding. Through active discussion, we would like you to experience the drafting process of a trial plan. In addition, it is desirable to read the following reference because we will deal with antidiabetic drugs as materials for group work: Ministry of Health, Labour and Welfare. “Guideline for Clinical Evaluation of Oral Hypoglycemic Agents”. https://www.pmda.go.jp/files/000208194.pdf, (accessed 2017-05-23).

Speaker(s)

Hideki  Mizusako

Hideki Mizusako

Clinical Development Department, Daiichi Sankyo Company, Limited, Japan

Points to Consider for Developing Clinical Study Protocol - Based on the Experience and Actual Cases -

Yuka  Sakagami

Yuka Sakagami

Reviewer, Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。